ChemicalBook >> CAS DataBase List >>GSK1324726A (I-BET726)

GSK1324726A (I-BET726)

CAS No.
1300031-52-0
Chemical Name:
GSK1324726A (I-BET726)
Synonyms
GSK1324726A;CS-1736;I-BET726;I-BET726; I-BET 726;GSK1324726A (I-BET726);I-BET726 (GSK1324726A);GSK1324726A (I-BET726) USP/EP/BP;GSK-1324726A,Apoptosis,GSK1324726A,Inhibitor,Epigenetic Reader Domain,inhibit;4-(cis-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid;4-((2S,4R)-1-acetyl-4-(4-chlorophenylamino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid
CBNumber:
CB62677051
Molecular Formula:
C25H23ClN2O3
Molecular Weight:
434.91
MDL Number:
MFCD28144683
MOL File:
1300031-52-0.mol
MSDS File:
SDS
Last updated:2023-06-08 09:01:57

GSK1324726A (I-BET726) Properties

Boiling point 707.3±60.0 °C(Predicted)
Density 1.304±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility insoluble in H2O; ≥1.87 mg/mL in EtOH with gentle warming and ultrasonic; ≥17.7 mg/mL in DMSO
form Powder
pka 4.20±0.10(Predicted)
InChIKey FAWSUKOIROHXAP-NPMXOYFQSA-N
SMILES C(O)(=O)C1=CC=C(C2C=CC3=C(C=2)[C@H](NC2=CC=C(Cl)C=C2)C[C@H](C)N3C(C)=O)C=C1

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P280-P305+P351+P338
NFPA 704
0
2 0

GSK1324726A (I-BET726) price More Price(17)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 16872 I-BET726 ≥98% 1300031-52-0 1mg $41 2024-03-01 Buy
Cayman Chemical 16872 I-BET726 ≥98% 1300031-52-0 5mg $142 2024-03-01 Buy
Cayman Chemical 16872 I-BET726 ≥98% 1300031-52-0 10mg $263 2024-03-01 Buy
Cayman Chemical 16872 I-BET726 ≥98% 1300031-52-0 25mg $601 2024-03-01 Buy
ApexBio Technology B1013 GSK1324726A 1300031-52-0 1unit $28 2021-12-16 Buy
Product number Packaging Price Buy
16872 1mg $41 Buy
16872 5mg $142 Buy
16872 10mg $263 Buy
16872 25mg $601 Buy
B1013 1unit $28 Buy

GSK1324726A (I-BET726) Chemical Properties,Uses,Production

Description

I-BET726 is an inhibitor of BET family proteins that binds BRD2, BRD3, and BRD4 with high affinity (IC50s = 41, 31, and 22 nM, respectively) and competes with tetra-acetylated histone 4 peptides for binding to the bromodomains of these proteins. It exhibits >1,000-fold selectivity for these proteins over other bromodomain-containing homologs. I-BET726 inhibits cell growth and induces cytotoxicity in neuroblastoma cell lines by modulating the expression of genes involved in apoptosis and Myc signaling. I-BET726 can be administered orally to animals, and it reduces tumor growth in mouse xenograft models of human neuroblastoma.

target

BRD2

References

[1] wyce a, ganji g, smitheman kn, chung cw, korenchuk s, bai y, barbash o, le b, craggs pd, mccabe mt, kennedy-wilson km, sanchez lv, gosmini rl, parr n, mchugh cf, dhanak d, prinjha rk, auger kr, tummino pj. bet inhibition silences expression of mycn and bcl2 and induces cytotoxicity in neuroblastoma tumor models. plos one. 2013 aug 23;8(8):e72967.

GSK1324726A (I-BET726) Preparation Products And Raw materials

Raw materials

Preparation Products

GSK1324726A (I-BET726) Suppliers

Global( 72)Suppliers
Supplier Tel Email Country ProdList Advantage
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Zhengzhou Alfa Chemical Co.,Ltd
+8618530059196 sale04@alfachem.cn China 12550 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29067 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 24738 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525 masar@topule.com China 8474 58
Aladdin Scientific
+1-833-552-7181 sales@aladdinsci.com United States 57511 58
Amadis Chemical Company Limited
571-89925085 sales@amadischem.com China 131981 58

GSK1324726A (I-BET726) Spectrum

1300031-52-0(GSK1324726A (I-BET726))Related Search:

4-((2S,4R)-1-acetyl-4-(4-chlorophenylamino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid 4-[(2S,4R)-1-Acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]benzoic acid GSK1324726A (I-BET726) 4-(cis-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid I-BET726; I-BET 726 CS-1736 4-[(2S,4R)-1-Acetyl-4-[(4-chlorophenyl)amino]-1,2,3,4-tetrahydro-2-methyl-6-quinolinyl]benzoic acid I-BET726 Benzoic acid, 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-1,2,3,4-tetrahydro-2-methyl-6-quinolinyl]- GSK1324726A (I-BET726) USP/EP/BP GSK1324726A GSK-1324726A,Apoptosis,GSK1324726A,Inhibitor,Epigenetic Reader Domain,inhibit I-BET726 (GSK1324726A) 1300031-52-0 Inhibitors